| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. | Director | Common Stock | 292,951 | $664,998 | $2.27 | 01 Jan 2026 | Direct |
| Opus Genetics, Inc. | Director | Stock Option (Right to Buy) | 79,592 | 30 Apr 2025 | Direct | ||
| TuHURA Biosciences, Inc./NV | Director | Options (Right to Buy) | 59,590 | 02 Jan 2025 | Direct | ||
| Kintara Therapeutics, Inc. | Director | Common Stock | 0 | 18 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | 01 Jan 2026 | 1 | $0 | 4 | Director | 05 Jan 2026, 16:23 |
| IRD | Opus Genetics, Inc. | 30 Apr 2025 | 2 | $0 | 4 | Director | 02 May 2025, 17:08 |
| HURA | TuHURA Biosciences, Inc./NV | 02 Jan 2025 | 1 | $0 | 4 | Director | 06 Jan 2025, 16:58 |
| IRD | Opus Genetics, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Director | 06 Jan 2025, 16:43 |
| HURA | Kintara Therapeutics, Inc. | 18 Oct 2024 | 2 | $0 | 4 | Director | 22 Oct 2024, 20:36 |
| HURA | Kintara Therapeutics, Inc. | 18 Oct 2024 | 0 | $0 | 3 | Director | 22 Oct 2024, 20:33 |
| IRD | Ocuphire Pharma, Inc. | 11 Jun 2024 | 2 | $0 | 4 | Director | 13 Jun 2024, 17:28 |
| IRD | Ocuphire Pharma, Inc. | 01 Jan 2024 | 1 | $0 | 4 | Director | 03 Jan 2024, 18:04 |
| IRD | Ocuphire Pharma, Inc. | 06 Jun 2023 | 2 | $0 | 4 | Director | 08 Jun 2023, 18:49 |
| IRD | Ocuphire Pharma, Inc. | 19 Apr 2023 | 1 | $0 | 4 | Director | 21 Apr 2023, 20:20 |
| IRD | Ocuphire Pharma, Inc. | 11 Jan 2023 | 1 | $0 | 4 | Director | 12 Jan 2023, 16:37 |
| IRD | Ocuphire Pharma, Inc. | 11 Oct 2022 | 2 | +$0.0787 | 4 | Director | 12 Oct 2022, 16:23 |
| IRD | Ocuphire Pharma, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director | 06 Jul 2022, 17:48 |
| IRD | Ocuphire Pharma, Inc. | 13 Jun 2022 | 1 | $0 | 4 | Director | 15 Jun 2022, 16:01 |
| IRD | Ocuphire Pharma, Inc. | 20 May 2022 | 1 | +$9,950 | 4 | Director | 24 May 2022, 09:43 |
| IRD | Ocuphire Pharma, Inc. | 18 Nov 2021 | 1 | +$7,000 | 4 | Director | 22 Nov 2021, 15:01 |
| IRD | Ocuphire Pharma, Inc. | 07 Jun 2021 | 1 | $0 | 4 | Director | 09 Jun 2021, 18:13 |